InvestorsHub Logo
icon url

bloomvest

07/18/14 5:57 AM

#94692 RE: BonelessCat #94684

OK so we now know 3-4 years of tox testing before ever launching a clinical trial in the US.

BK points out that it does penetrate the blood brain barrier (yikes) and Cides are not conventional. All this means more testing.

BK, or anyone, What can NNVC possibly do to shorten the tox timeline?



Nanoviricides fully circulate throughout the entire system. There is no blood brain barrier issue as these are not conventional drugs that interact with the system. So far in animal studies the drug has shown no interaction other than the normal metabolic and eliminatory system. First evidence of blood brain barrier not being an issue was the efficacy of the nanoviricide against Rabies which replicates in the neurosystem, including the cerebrum.

icon url

noretreat

07/18/14 6:27 AM

#94694 RE: BonelessCat #94684

It is fine to state those conclusions, and I tend to think that is exactly what will be found. BUT, Flucide has never been in a human (or has it?), and your statements will almost certainly have to be demonstrated. Why not sooner rather than later?